{"disease":{"id":"tattoo-removal","name":"tattoo removal"},"drugs":{"marketed":[{"drug_id":"procaine","indication_name":"Tattoo Removal","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Isocain","generic_name":"PROCAINE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A","drug_class":"Amide Local Anesthetic [EPC]","quality_score":34,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06202274","title":"Clinical Study to Evaluate the Safety and Efficacy of Candela Technology","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Candela Corporation","has_results":false},{"nct_id":"NCT03866304","title":"Performance Evaluation of Tattoo Removal","phase":"NA","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"LigthSense Israel Ltd","has_results":false},{"nct_id":"NCT05102617","title":"Post Market Usability Evaluation Of The PicoSure Pro Device","phase":"NA","overall_status":"COMPLETED","enrollment_count":23,"lead_sponsor_name":"Cynosure, Inc.","has_results":false},{"nct_id":"NCT03290547","title":"Pilot Study of Multi-wavelength Laser for Tattoo Removal","phase":"NA","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Cutera Inc.","has_results":true},{"nct_id":"NCT02912507","title":"Split-tattoo Study Comparing the Safety and Efficacy of 670nm Picosecond Laser Versus 755 nm for Tattoo Removal","phase":"NA","overall_status":"COMPLETED","enrollment_count":11,"lead_sponsor_name":"Cutera Inc.","has_results":true}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}